wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27853223-6D9E1D1B-18D5-4837-B87A-D1B89700BB26
Q27853223-6D9E1D1B-18D5-4837-B87A-D1B89700BB26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853223-6D9E1D1B-18D5-4837-B87A-D1B89700BB26
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
P2860
Q27853223-6D9E1D1B-18D5-4837-B87A-D1B89700BB26
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27853223-6D9E1D1B-18D5-4837-B87A-D1B89700BB26
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
40a616463e016bf1431569d5a5384c1957c0bf29
P2860
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity.